Sujit Reddy Gandhari, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5800 Foxridge Dr, Ste 240, Mission, KS 66202 Phone: 913-362-5434 |
Dr. Douglas Merrill Rope, M. D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5920 Nall Ave, Suite 107, Mission, KS 66202 Phone: 913-677-1445 |
Dr. Drew Wesley Moore, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5800 Foxridge Dr Ste 240, Mission, KS 66202 Phone: 913-261-3153 |
Dr. David Christian Murphy, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5030 Glenwood Dr., Mission, KS 66202 Phone: 785-410-3859 |
News Archive
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib, a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer.
Researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) have found that in low-income neighborhoods, misinformation about access to emergency contraception is a common occurrence.
This time of year many people make resolutions to live a healthier lifestyle, exercise more, lose weight and eat better. For the adolescents who are extremely obese in this country, diet and exercise alone often are not enough to get their weight down.
Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.
The standard monthly premium for Medicare Part B in 2007 will increase to $93.50 from $88.50, CMS Administrator Mark McClellan announced on Tuesday, the Washington Post reports.
› Verified 9 days ago